Vimarsana
Biggest News Aggregation in the World

Antje Witte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antje Witte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antje Witte Today - Breaking & Trending Today

UCB : Acquisition of own shares - MarketScreener - Vimarsana News

UCB : Acquisition of own shares - MarketScreener

Regulated information In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, UCB SA/NV hereby discloses...

UCB : General Meeting of Shareholders 2024 - Vimarsana News

UCB : General Meeting of Shareholders 2024

UCB's General Meeting of Shareholders 2024 For financial year 2023: Gross dividend of € 1.36 per share , payable 30 May 2024 ...

UCB : receives European Commission approval for BIMZELX▼(bimekizumab) as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa - Vimarsana News

UCB : receives European Commission approval for BIMZELX▼(bimekizumab) as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa

UCB receives European Commission approval for BIMZELX[®]▼ as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa ...

UCB : presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology (AAN) Annual Meeting -April 12, 2024 at 01:05 am EDT - Vimarsana News

UCB : presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology (AAN) Annual Meeting -April 12, 2024 at 01:05 am EDT

UCB presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology Annual Meeting Diverse and...

UCB : Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY▼ (romosozumab) can help to close the treatment gap in osteoporosi - Vimarsana News

UCB : Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY▼ (romosozumab) can help to close the treatment gap in osteoporosi

Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY[®]▼ can help to close the treatment gap in osteoporosi The first cohort...